X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3%
Fri, 10 Aug

NATCO PHARMA has announced its results for the quarter ended June 2018. Here is a detailed performance review of the same:

NATCO PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-17*
3
Mar-18*
3
Jun-18*
QoQ ChangeYoY Change
Net SalesRs m4,4537,6785,386-29.9%21.0%
Other incomeRs m3420135978.6%955.9%
TurnoverRs m4,4877,8795,745-27.1%28.0%
ExpensesRs m3,0863,8453,210-16.5%4.0%
Gross profitRs m1,3673,8332,176-43.2%59.2%
DepreciationRs m1501801842.2%22.7%
InterestRs m393028-6.7%-28.2%
Profit before taxRs m1,2123,8242,323-39.3%91.7%
TaxRs m275827512-38.1%86.2%
Profit after taxRs m9372,9971,811-39.6%93.3%
Gross profit margin%30.749.940.4
Effective tax rate%22.721.622.0
Net profit margin%20.938.031.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 21.0% on a year-on-year (YoY) basis. The expenses were up by 4.0% YoY during the same period.
  • The company's operating profit increased by 59.2% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 40.4% in 1QFY19 as against 30.7% in 1QFY18.
  • Depreciation charges and finance costs increased by 22.7% YoY and 28.2% YoY, respectively.
  • Other income increased by 955.9% YoY during the quarter.
  • Net profit for the quarter increased by 93.3% YoY. Net profit margins during the quarter increased from 20.9% in 1QFY18 to 31.5% in 1QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 29.9% on a quarter-on-quarter (QoQ) basis. The expenses were down by 16.5% QoQ during the same period.
  • The company's operating profit declined by 43.2% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 40.4% in 1QFY19 as against 49.9% in 4QFY18.
  • Net profit for the quarter declined by 39.6% QoQ, while net profit margins declined from 38.0% in 4QFY18 to 31.5% in 1QFY19.

To see how NATCO PHARMA has performed over the last eight quarters, please visit here.

NATCO PHARMA Share Price Performance

Over the last one year, NATCO PHARMA share price has moved up from Rs 696.7 to Rs 773.0, registering a Gain of Rs 76.4 or around 11.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,253.9 (down 1.0%). Over the last one year it has moved up from 12,779.2 to 14,253.9, a gain of 1,475 points (up 11.5%).

Overall, the S&P BSE SENSEX is up 19.1% over the year.

Current Valuations

At the current price of Rs 773.0, the price to earnings (P/E) ratio of NATCO PHARMA stands at 16.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 17.7 times.

Equitymaster requests your view! Post a comment on "NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3%". Click here!

  

Related Views on News

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

7 Bluechips to Profit from Tech Disruption(Profit Hunter)

Jun 17, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Jun 24, 2019 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 5-YR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS